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DegraWion of the peroxisomal enzymes fatty acyl-CoA oxidase and cut&se was studied in hepatocytes isolated from rats treated with clofibrate 
and from control rats. HepatocyLes were incubated in the absence of amino acids in order to ensure maximal flux through the autophagic pathway 
and in the presence of cycloheximidc to inhibit protein synthesis, (I) Degradation of the two psroxisomal enzymes in hepatocytes from clofibrate-fed 
rats, but not in hepatocytes from control rats, was much faster than that of other intracellular enzymes, This increased egradation of the 
pcroxisomal enzymes was almost completely prevented by 3-methyladeninr, an inhibitor of mscroautophagic squmtration. (2) The increased 
degradation of the peroxisomal enzymes was also inhibited by a long-chain (Cl6:O) and a very-longchain (C26:O) fatly acid, but not by Cl2:0, 
a medium-chain fatty acid, or by C&O, a short-chain fatty acid. These results provide direct evidence for the proposal thal autophagic sequestration 
can be highly selective [( 1987) Exp. Mol. Pathol. 46, 1 l4-1221. It is concluded that preferential ulophagy of peroxisomes is prevented when :hese 
organclles are supplied with their fatty acid substrates. 
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I. INTRODUCTION 
Hepatic protein degradation mainly occurs by mac- 
roautophagy [1,2], During this process, parts of the cy- 
toplasm are surrounded by a sequestering membrane 
originating from the endoplasmic reticulum [3]. Auto- 
phagosomes thus formed, which may even contain 
whole organelles, fuse with existing or newly formed 
lysosomes, aud this is followed by degradation of the 
sequestered macromolecular material. Although auto- 
phagic proteolysis of cytosolic proteins is largely non- 
selective in that they are sequestered in the same ratio 
as they occur in the cytosol [4,5], some cytosolic pro- 
teins may be specifically targeted to the lysosomes be- 
cause of the presence near the N-terminus of the peptide 
sequence KFERQ, which acts as an autophagic target- 
ing signal [G]. Morphometric measurements have indi- 
cated that different cell compartments turn over with 
different half lives [7]. Another indication for selective 
autophagy is that regulation by glucagon of hepatic 
autophagic RNA and protein degradation proceeds by 
different mechanisms [S]. Furthermore, administration 
of antilipolytic agents agents to starved rats results in 
preferential autophagic breakdown of hepEtic per- 
oxisomal enzymes at rates which exceed those of en- 
zymes in other cellular compartments [9,10]. We show 
here that selective autophagic breakdown of per- 
oxisomal enzymes also occurs in hepatocytes isolated 
from clofibrate- treated rats and incubated in the ab- 
sence of amino acids in order to ensure maximal flux 
through the autophagic pathway. It is further shown 
that long-chain fatty acids protect peroxisomal enzymes 
against his degradation. 
2. MATERIALS AND METHODS 
Rat hepatocyles were isolated from fed male Wistar rats (200-250’ 
g) as described previously [1 I]. Clofibrate was administered uring 3 
weeks by mixing this drug with the lab chow by grinding (5 g clofi- 
bratelkp chow) [12]. The rats had free access to the food. 
Hepatocytes (5-10 mg dry mass/ml) were incubated at 37OC in 
closed 25.ml plastic counting vials with Krebs-Hens&it bicarbonate 
medium containing 1.3 mM Cazf, IO mM sodium HEPES (pH 7.4). 
2OyM cyclohcximide, 20 mM glucose and I mM octanoate. The gas 
phase was 95% O? plus 5% CO2 (v/v) and was refreshed every 
30 min. 
Abbreviuriotzs: C8:O. oclanoale; C12:0, lauratc; Cl6:0, palmitate; 
C26:0, cerotate. 
Corrrspondencc odddress: A.J, Meijer, c/o Mrs. J.E, Vlugt-van Daalen, 
Publications Sccrctirry, EC. Slatcr instiiuie for Siocheniical Rc- 
search, Academic Medical Centre, University of Amsterdam, Mei- 
bergdreef 15, I 105 AZ, Amsterdam, The Netherlands. Fax: (31) (20) 
691 5519. 
Enzyme assays were performed on samples of the cell suspension. 
In order to eliminate the contribution of dead cells to the enzyme 
activities, the samples were first centrifuged through 35% (m/v) Percoll 
(‘Phannacia) for 10 min at 50 x g at OOC. During this procedure, dead 
cells remain at the top while intact cells arrive at the bottom of the 
centrifuge tube 1131. In order to avoid underestimation of enzyme 
activity due to latency, all assays were performed in the presence of 
0.1% Triton X-100, Enzyme activities were measured according to 
standard proc&ures: for lactate dchyd:ozeecase see [14]; glutamate 
dehydrogenase [ 141; p-hexosaminidase [ 141: catalase [I 41; glucozx 6- 
phosphatasc [!5]. Fatty acyl-CoA oxidase was measured essentially 
according to Vameq [16], in the presence of palmitoyl-CoA, FAD, 
prroxidase, and homovanillic acid, with azide added to inhibit cata- 
hx. 
Proteolysis was measured as the rate ofrelease ofvnline becatsc this 
amino acid is not catabolised in rat liver [ 17,i8]. For the measurement 
of proteolysis, samples of the eel! suspension were acidified Gth 
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Tublc t 
Bnymc Activity relative to that in rat fed normal 
diet 
Clofibrate ClOliblTdC Clofibratc 
treated then normal then fasted 
diet 
Lactate dchydrogenasc 1.3 
Glutamate dehydrogenase 0.8 
Glucose-6.phosphatase 0.8 
p-Hexoseminidase 1.6 








by centrifugation, the extract was neutraliscd to pH 7 with a solution 
containing 2 M KOH and 0.3 M MOPS. ATP was determined Ruori- 
metrically according to Williamson and Corkey [19]. 
Enzymes and nucleotidcs were purchased from Bochringcr GmbH 
(Mannhcim, Germany). Clotibrate and fatty acids were obtained from 
Sigma Chemical Co, (St, Louis, MO, USA), 3-Methyladcnine (6. 
amino-3-methylpurine) was obtained from Fluka AG (Buchs, Switzer- 
land). 
The statistical significance of the difference between groups of ob- 
servations was tested with Student’s r-test. 
3. RESULTS 
Effect of clofibrate feeding and withdrawal on enzyme activities in rat 
liver. Rats were fed with clcifibrate for 3 weeks, after which the rats 
were either sacrificed, or fed a normal diet withour clofibrate for 2 
days, or starved for 2 days. Enzyme acitities were measured inhepato- 
cytes isolated from the livers of these rats without further incubation. 
Enzyme activities are expressed relative to the values for hcpatocytcs 
isolated from rats fed a normal diet. Data for each condition are the 
mean values of 2 hcpatocyte preparations. 
sulphosalicylic acid (final concentration 4%; m/v). After removal of 
the protein by centrifugation, tbesamples were brought o phi 2-2 with 
3 M LiOH, The amino acid analysis was carried out on an LKB 
alpha-plus amino acid analyscr using a lithium citrate buffer system. 
Cell samples for the determination of ATP were acidilied in the cold 
with HCIO, (final concentration 3; m/v), After removal of the protein 
In order to study degradation of peroxisomes, the 
rats were first treated with clofibrate in order to induce 
hepatic proliferation of peroxisomes [20,2 11. Activity of 
long-chain acyl-CoA oxidase increased more than 12- 
fold by this treatment, while catalase activity increased 
by 40% (Table I). These data are in agreement with 
those published by other authors [l&22]. The activity 
of lactate dehydrogenase, glutamate dehydrogenase and 
glucose 6-phosphatase, markers for cytosol, mitochon- 
dria and endoplasmic reticulttm, respectively, were not 
affected very much, while the lysosomal enzyme B-hex- 
osaminidase increased by 60% (Table I). When after 3 
weeks of feeding with clofibrate the drug was either 
















Lactate dehydrogenasc 83.1 -I 3.2 101.9 + 1.2* 82.0 2 0.8 86.1 + 2.5 85.8 k 1.7 
Glutamate dchydrogenase 80.6 t 1.5 99.6 1: 0.4” 80.8 2 3.6 84.4 2 1.2 78.9 2 1.5 
Glucose-6phosphatase 8601 -c I.1 99.3 c 1.8” 85.3 f 0,5 88.7 sf: 5. I 86-5 + 2.7 
@Hexosaminidasc 86.8 k 2.4 101.6 z C.9* 81.8 * 5.3 89.9 * I.9 88.7 k 3s 
Fatty acyl-CoA oxidasc 89.3 + 1.2 99.7 2 0.2” 87.3 r 2.5 94.8 + 2.9 91.5 2 16 
Calalase 87.7 r 3.0 99.5 & i.O* 83.9 + I.2 89.2 4 3.5 88.8 z!z 2.1 
Valinc (nmol~gdry mass-‘emin-‘) 
ATP @molg dry mass-‘) 
241 *8 122 r I@ 
9.4 * I.0 I I .4 1 0.7 
255 ?I I7 
10.2 2 0.4 
250 16 244 +4 





Fatty acyl-CoA oxidasc 
Catalase 
85.4 ?r I.6 99.6 !: 0.9’ 
78,8 +, 3.9 96.8 z!z 2.8” 
88,8 + 4.4 98.6 = 1.3* 
87.3 z 4.5 96.6 k 4.2 
56,6 f 4.9” 97.7 + 3.2’ 
67.8 * 2.7** 102.4 c 3.34 
82.2 + 3.0 
84.7 zb 4.3 
88.4 u 2.7 
84.0 f I.8 
51.2 + 3.4”” 
65.5 + l.4”* 
90.5 + I.0 86.0 + 2.0 
82.5 2 I.2 83.8 + 2.6 
87.6 I!Z 3.6 85.7 + 2.4 
85.5 i: 1.8 85.7 !I 3.6 
94.5 3 1.7’ 93.3 z 2.7’ 
88.4 z! I.3 90.1 ?: 1.1’ 
Va!inc (nmol.g,dry mass-‘,min-I) 216 f 32 116 + 16* 216 (2) I88 227 I84 221 
ATP @molg dry mass-‘) 9,2 ‘r- I.7 12.2 * 1.3” 10.0 (1) 9.0 + 1.4 8.6 2 1.4 
80.2 !I 0.8 
79.3 + 0.6 
87.0 ?: 1.2 
83.7 r 7.0 
88.4 !: 0.2 
84,2 2 1.9 
256 f 12 
9.6 2 2.2 
84.7 !I 0.2 
83.0 f 2.1 
91.8 !: 3.8 
84.0 f. 4.0 
55.8 + 3.6”* 
69.3 4 2.5”* 
204 k 27 
8.2 r 1.4 
Autophagy of enzymes in hepatocytcrj isolated from rats treated with clotibrate and from normal rats. Hepatocytcs were isolated and incubated 
for 4 h under the conditions outlined in Methods and Materials in the absence of amino acids and (where indicated) with 10 mM 3-mcthyladenine, 
400/1M C12:O fatty acid, 200ifM Cl6:O fatty acid, 40yM C26:O f2tty it&d, or !O m@nl a-cyclodextrin (the ttbsorbcnt of Cl2:0, Cl6:O and C26:O 
fatty acids). Intracellular ATP wns measured after the 4 h incubation period. Enzyme activities are expressed as perccntoges of the activity in 
hepatocytes immediately after isolation. Values are the means f SD of 3 separate (normal fed rats) hepatocytc preparations and 5 separate 
hcpatocytc preparations (clofibrate fed rats). 
*Significantly different (P<O,O5) from the corresponding control (without addition). 
**Significantly different (P<O.OS) from the value for lacttitc dchydrogcnasc obtained under the same conditions. 
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ued for two days, or the rats were starved for two days, 
fatty acyl-CoA oxidase activity greatly decreased while 
catalase fell back to normal values (Table I). Starvation 
led to an increase in p-hexosaminidase activity (Table 
I), in agreement with similar observations by Kovacs et 
al. [23] on cathepsin D, another lysosomal enzyme. 
These measurements in vivo do not, of course, discrim- 
inate between increased rates of enzyme degradation, 
decreased rates of enzyme synthesis, or a combination 
if both. In order to study the breakdown of peroxisomal 
enzymes independently of protein synthesis we isolated 
hepatocytes from rats treated with clofibrate and incu- 
bated the cells in the presence of cycloheximide to in- 
hibit protein synthesis. Control experiments revealed 
that at the concentration of cycloheximide used (20yM) 
protein synthesis was inhibited by more than 95% (not 
shown, but see 1241). Glucose and octanoate were pres- 
ent to provide the cells with a source of energy. Amino 
acids were omitted from the medium in order to ensure 
maximal flux through the autophagic pathway [1,2]. 
After 4 h of incubation, disappearance of the per- 
oxisomal enzymes fatty acyl-CoA oxidase and catalase 
was much higher than that of the other four, non-per- 
oxisomal, marker enzymes (Table 2). The rate of disap- 
pearance of lactate dehydrogenase (16% in 4 h) was 
similar to that observed by Kopitz et al. [ 151 in normal 
hepatocytes. The disappearance of the peroxisomal en- 
zymes, like that of the non-peroxisomal enzymes, was 
largely prevented by 3-methyladenine, a strong inhibi- 
tor of autophagic sequestration [25] (see Table 11). 
Breakdown of the peroxisomal enzymes, but not that of 
the other enzymes, was inhibited by a long-chain fatty 
acid (Cl6:O) and a very-long-chain fatty acid (C26:O). 
Addition of a-cyclodextrin, to which these fatty acids 
were bound, had no effect (Table II). The medium-chain 
fatty acid C12:O was not effective (Table II). 
intracellular ATP was not significantly different 
under the various conditions except hat in the presence 
of 3-methyladenine the concentration of ATP slightly 
increased, which is in agreement with our previous ob- 
scrvations in normal hepatocytes [ll]. Overall prote- 
olytic flux, as measured by valine production, was in- 
hibited by about 50% by ‘3-methyladenine, while the 
fatty acids ClG:O and C26:O inhibited flux by 15% 
(Table II). 
Accelerated egradation of peroxisomal enzymes was 
not observed in hepatocytes i olated from control rats 
that had not been exposed to cloflbrate (Table I). 
4. DISCUSSION 
In recent reviews on peroxisomes [X-28] emphasis 
has been placed on the biogenesis of these organelles but 
no attention was paid to their degradation. This is sur- 
prising since the level of peroxisomes in the cell is deter- 
mined by the relative rates of both synthesis and degra- 
dation. At steady state, these rates must be equal. For 
instance, whereas feeding rats with compounds like 
clofibrate leads to a remarkable increase in the number 
of peroxisomes and to a concomitant increase in the rate 
of synthesis of some peroxisomal membrane proteins 
(cf. [28] for a review) and of fatty acid oxidation en. 
zymes [29], the large increase in the number of per. 
oxisomes in the liver of rats fed with a high-fat diet is 
mainly due to depressed egradation of peroxisomes in 
the liver of rats fed with a high-fat diet is mainly due to 
depressed egradation of pcroxisomes [30]. 
It has been suggested that autophagy plays a role in 
the degradation of peroxisomes [7,9, tO,20,21,31-331, al-
though the extent to which it influences degradation is 
still uncertain [34]. For instance, the involvement of 
autophagy in the turnover of peroxisomes in fibroblasts 
from patients with the Zellweger syndrome recently has 
been established by us [35] and evidence is accumulating 
that under certain conditions autophagy of peroxisomes 
may be selective in that the degradation rate of these 
organellcs is more rapid than that of other cellular 
structures [7,9,10,30]. 
In our experimental system, i.e. hepatocytes isolated 
from rats treated with slofibrate selective degradation 
of peroxisomal enzymes was, indeed, observed. The fact 
that 3-methyladenine completely prevented the decrease 
in activity of both fatty acyl-CoA oxidase and catalase 
indicates that macroautophagy must have been rcspon- 
sible for the observed rapid removal of peroxisomes 
from the hepatocytes. The rate OF autophagic break- 
down of the peroxisomes was extremely high. about 
10% per hour. Of course, we deliberately chose condi- 
tions under which flux through the autophagic pathway 
was maximal, i.e. in the absence of amino acids, while 
protein synthesis was simultaneously inhibited. How- 
ever, also in vivo the rate of autophagic breakdown of 
peroxisomes was considerable: two days after with- 
drawal of clofibrate from the diet 60-70% of fatty acyl- 
CoA oxidase disappeared. This value agrees well with 
a reported half life of peroxisomes of 1.4 days in the 
livers of rats under similar conditions [21,29] and of 2 
days in rats switching from a high-fat diet (which also 
causes an increase in the number of peroxisomes) back 
to a normal diet [30]. 
Extremely intriguing is the finding that autophagic 
breakdown of the peroxisomal enzymes in our experi- 
mental system was sensitive lo inhibition by a long 
chain (C16:O) and a very long-chain (C26:O) fatty acid, 
but was not inhibited by a medium-chain fatty acid 
(Cl2:O). Presumably, there was no inhibition by oc- 
tanoate (C&O). The media used for incubating the hepa- 
tocytes always contained octanoate in order to ensure 
an adequate ATP supply, .4TP being required at several 
steps in the autophagic pathway l36.371. 
The selective ffect of the Iong-chain and very-:ong- 
chain fatty acid on peroxisome degradation was also 
reflected in their effecis on overall proteolysis. While 
inhibition by 3-methyladenine was about 50% after 4 h 
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of incubation, the inhibition caused by the long-chain 
and very-long-chain fatry acids was only 15% (Table II). 
Because these fatty acids only inhibited the degradation 
of peroxisomes, but not that of other cell components 
(Table II), it can be concluded that in hepatocytes from 
rats treated with clofibrate 100 x 15150 = 30% of the 
total cell protein degraded by macroautophagy was de- 
rived from the peroxisomes. In the experiments de- 
scribed in this paper, inhibition by 3-methyladenine of
overall proteolysis was less than the GO-70% inhibition 
usually observed in hepatocytes from normal rats 
[ 11,25]. The explanation for this could be that proteoly- 
sis in hepatocytes isolated from rats treated wih clofi- 
brate proceeded with a lag period of about 1 h, in con- 
trast to a lag of 20 min observed in normal hepatocytes 
(results not shown). 
Our results are in complete accordance with, and pro- 
vide an explanation for, the data obtained for a situa- 
tion in vivo by Horie and Suga [30], who showed that 
hepatic peroxisomal proliferation after feeding rats a 
high-fat diet is mainly due to inhibition of peroxisomc 
degradation, which the authors ascribe to inhibition of 
lysosomal functions. Apparently, long-chain and very- 
long-chain fatty acids, which are substrates for per- 
oxisomes, protect peroxisomes against autophagic deg- 
radation. 
We did not observe selective degradation of per- 
oxisomes in hepatocytes isolated from control rats. 
However, this may have been due to protection by en- 
dogenous long-chain fatty acids. Interestingly, it was 
found by Locci Cubeddu et al. [9] that long-term starva- 
tion of rats did not affect the activity of peroxisomal 
fatty acyl-CoA oxidase in vivo, even though the liver 
weight decreased by 45%, which is known to be due to 
macroautophagy [ 11. However, administration of anti- 
lipolytic agents did result in hepatic autophagic per- 
oxisome degradation [9,10]. Although these effects were 
ascribed to the increased glucagon/insuIin ratio caused 
by these agents [9,10], our results indicate that the de- 
creased supply of endogenous fatty acids per se may 
have been responsible for the induction of peroxisome 
degradation under these conditions. 
As to the mechanism by means of which long-chain 
and very-long-chain fatty acids are able to protect per- 
oxisomes against autophagic degradation one can only 
speculate. A possibility is that one of the peroxisomai 
membrane proteins contains a peptide-signai sequence, 
in analogy to the KFERQ sequence reported by Wing 
et al. [G], which is rendered inactive by acylation and 
which becomes deacylated, and thus susceptible for au- 
tophagy, when the concentration of long-chain fatty 
acids falls. 
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